Heparin-Protamine Iron Nanoparticles for Cell Tracking
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for safe and effective non-invasive monitoring tools for cell-based therapeutic products and cell-derived biologics, particularly for labeling and tracking low-phagocytic and sensitive cells, which are challenging due to their physiological characteristics and sensitivity to foreign materials, and existing technologies face difficulties in integrating with standard clinical imaging protocols.
Innovation Solution
The development of nanoparticles comprising heparin, protamine, and an iron-based imaging agent, where the contrast agent is conjugated to heparin or protamine, and a magnetic separation process is used to produce magnetically enriched particles with enhanced MRI signal for cell labeling and tracking, allowing for efficient labeling in both serum-containing and serum-deprived conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional cell labeling methods are used, then cells can be tracked, but the labeling process is time-consuming and may compromise cell viability
Solution Approach 1:
The patent modifies the physical and chemical parameters of the labeling system by using superparamagnetic iron oxide nanoparticles with specific size ranges (20-200 nm) and surface coatings (dextran, carboxydextran, or polyethylene glycol). These parameter changes enable rapid cellular uptake and strong MRI signal enhancement, reducing labeling time while maintaining cell viability for tracking applications
2Measurement precision
If iron concentration in nanoparticles is increased to enhance MRI signal, then imaging sensitivity improves, but cell toxicity may increase
Solution Approach 1:
The patent creates composite nanoparticle structures combining superparamagnetic iron oxide cores with biocompatible surface coatings (dextran, carboxydextran, or polyethylene glycol). This composite approach allows high iron concentrations (40-80% by weight) for strong MRI signal while the surface coating provides biocompatibility and reduces cell toxicity, enabling effective cell tracking
Solution Approach 2:
The patent concentrates the magnetic imaging function in the iron oxide core while the surface coating provides the biocompatible interface with cells. This local quality differentiation allows the iron-rich core to generate strong MRI signals while the coating layer protects cells from toxicity, resolving the contradiction between signal strength and cell viability
3Productivity
If nanoparticle size is reduced to improve cellular uptake, then labeling efficiency increases, but manufacturing precision becomes more difficult
Solution Approach 1:
The patent specifies precise nanoparticle size parameters (20-200 nm diameter) and uses controlled synthesis methods to achieve this range. The surface coating parameters (dextran, carboxydextran, or polyethylene glycol with specific molecular weights) are also controlled to maintain size uniformity. These parameter controls enable efficient cellular uptake while maintaining manufacturing precision through standardized production protocols
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanoparticles provide high cell-labeling efficiency and a favorable safety profile, enabling effective tracking of cells using conventional MRI sequences, with the ability to label cells in less than three hours and maintain cell viability, even at increased iron concentrations, facilitating integration into clinical workflows.
Implementation Method 1
an iron-based imaging agent, wherein the contrast agent is conjugated to the heparin and/or the protamine
Implementation Method 2
a magnetic separation process is used to produce magnetically enriched particles with enhanced MRI signal
Data Source
AI summary
Nanoparticles, compositions, and methods are disclosed for manufacturing and using the nanoparticles and compositions for cellular tracking, drug encapsulation, and biologic tracking.